Home
>
National Drug Code (NDC)
>
Survanta
Survanta - 0074-1040-04 - (Beractant)
Drug Information of Survanta
| Product NDC: | 0074-1040 |
| Proprietary Name: | Survanta |
| Non Proprietary Name: | Beractant |
| Active Ingredient(s): | 25 mg/mL & nbsp; Beractant |
| Administration Route(s): | ENDOTRACHEAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Survanta
| Product NDC: | 0074-1040 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020032 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910701 |
Package Information of Survanta
| Package NDC: | 0074-1040-04 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) > 4 mL in 1 VIAL, SINGLE-USE |
NDC Information of Survanta
| NDC Code | 0074-1040-04 |
| Proprietary Name | Survanta |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) > 4 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0074-1040 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Beractant |
| Dosage Form Name | SUSPENSION |
| Route Name | ENDOTRACHEAL |
| Start Marketing Date | 19910701 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | BERACTANT |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Alveolar Surface Tension Reduction [PE],Surfactant [EPC],Surfactant Activity [MoA] |
